Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Q2 Revenues Rise

NEW YORK, Aug. 7 – Pyrosequencing, of Uppsala, Sweden, said on Tuesday that its second-quarter revenues jumped to $2.3 million, compared to $580,000 in the year-ago period.

The SNP company said the increase came from the sale of 20 of its PSQ 96 Systems during the quarter compared to nine instruments sold in the same quarter one year ago. 

The company also reported an increased net loss to $3.2 million, or 9 cents per share, compared with $2.5 million, or 10 cents a share, in the year-ago period.

At the end of June, the company had $67.1 million in cash, cash equivalents, and investments in high-grade debt securities, including investments with maturity dates exceeding 12 months.

Last month, a research group at Uppsala University had agreed to use Pyrosequencing technology to examine the genomes of antibiotic resistant bacteria, according to the company.

As GenomeWeb  reported, the deal calls for an Uppsala researcher to use several applications of the Pyrosequencing technology to analyze antibiotic resistant strains of Helicobacter pylori and Mycobacterium tuberculosis , the bacteria responsible for gastric ulcers and tuberculosis, respectively. 

Pyrosequencing will provide technical support throughout the collaboration, which will last one year.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.